In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Aurora Cannabis Inc (NASDAQ: ACB) was $4.75 for the day, up 2.37% from the previous closing price of $4.64. In other words, the price has increased by $2.37 from its previous closing price. On the day, 0.85 million shares were traded. ACB stock price reached its highest trading level at $4.785 during the session, while it also had its lowest trading level at $4.55.
Ratios:
Our analysis of ACB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.60 and its Current Ratio is at 3.30. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.07.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 260699472 and an Enterprise Value of 292444256. As of this moment, Aurora’s Price-to-Earnings (P/E) ratio for their current fiscal year is 30.14, and their Forward P/E ratio for the next fiscal year is 24.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.12 while its Price-to-Book (P/B) ratio in mrq is 0.65. Its current Enterprise Value per Revenue stands at 0.912 whereas that against EBITDA is 4.736.
Stock Price History:
The Beta on a monthly basis for ACB is 1.94, which has changed by -0.2952522 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, ACB has reached a high of $8.65, while it has fallen to a 52-week low of $3.42. The 50-Day Moving Average of the stock is 3.38%, while the 200-Day Moving Average is calculated to be -6.84%.
Shares Statistics:
ACB traded an average of 3.01M shares per day over the past three months and 1262230 shares per day over the past ten days. A total of 54.88M shares are outstanding, with a floating share count of 54.67M. Insiders hold about 0.39% of the company’s shares, while institutions hold 9.73% stake in the company. Shares short for ACB as of 1744675200 were 4946977 with a Short Ratio of 1.65, compared to 1741910400 on 4327704.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.65 and -$0.65 for the fiscal current year, implying an average EPS of -$0.65. EPS for the following year is -$0.33, with 1.0 analysts recommending between -$0.33 and -$0.33.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 4 analysts. It ranges from a high estimate of $92.6M to a low estimate of $87M. As of the current estimate, Aurora Cannabis Inc’s year-ago sales were $67.41MFor the next quarter, 4 analysts are estimating revenue of $99.67M. There is a high estimate of $105M for the next quarter, whereas the lowest estimate is $94M.
A total of 5 analysts have provided revenue estimates for ACB’s current fiscal year. The highest revenue estimate was $345.51M, while the lowest revenue estimate was $339.8M, resulting in an average revenue estimate of $342.24M. In the same quarter a year ago, actual revenue was $270.28MBased on 6 analysts’ estimates, the company’s revenue will be $370.15M in the next fiscal year. The high estimate is $391M and the low estimate is $326.51M.
